EUVIMEDEUVIMED entdecken
Crossref

Comparative study of olanzapine and risperidone in the control of positive and negative symptoms in the treatment of schizophrenia

International Journal of Pharmaceutical Chemistry and Analysis · 2020

DOI: 10.18231/2394-2797.2018.0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Chemistry and Analysis, 2020.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the efficacy of olanzapine and risperidone in the treatment of positive and negative symptoms of schizophrenia. Materials and Methods: The study was conducted in MGM medical college Navi Mumbai between October 2012 to September 2014. The study included 110 patients of schizophrenia. The positive and negative symptoms were assessed with the help of the PANSS (positive & negative symptom score) scale.

Results

We observed that the mean percentage reduction in score in the positive scale of PANSS was 48.74% in the risperidone and 49.40% in the olanzapine group .The negative score reduced by 56.32% in the Risperidone group and by 61.59% in the olanzapine group on the PANSS. Conclusion: olanzapine was superior to risperidone in controlling the positive as well as negative symptoms of schizophrenia clinically but the results were not statistically significant. Keywords: Olanzaine, Risperidone, Schizophrenia.

Zitieren

APA

(2020). Comparative study of olanzapine and risperidone in the control of positive and negative symptoms in the treatment of schizophrenia. International Journal of Pharmaceutical Chemistry and Analysis. https://doi.org/10.18231/2394-2797.2018.0002

Vancouver

Comparative study of olanzapine and risperidone in the control of positive and negative symptoms in the treatment of schizophrenia. International Journal of Pharmaceutical Chemistry and Analysis. 2020. doi:10.18231/2394-2797.2018.0002

BibTeX
@article{euvimed2020,
  title = {Comparative study of olanzapine and risperidone in the control of positive and negative symptoms in the treatment of schizophrenia},
  journal = {International Journal of Pharmaceutical Chemistry and Analysis},
  year = {2020},
  doi = {10.18231/2394-2797.2018.0002}
}
Kostenlos starten →